| abstract |
This invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, or a phan-naceutically acceptable salt or solvate or stereoisomer thereof The compounds of this invention possess both β2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Such compounds are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma. |